Dolores Merino

1.9k total citations
68 papers, 1.2k citations indexed

About

Dolores Merino is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Dolores Merino has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hepatology, 45 papers in Epidemiology and 27 papers in Infectious Diseases. Recurrent topics in Dolores Merino's work include Hepatitis C virus research (54 papers), Liver Disease Diagnosis and Treatment (35 papers) and HIV/AIDS drug development and treatment (24 papers). Dolores Merino is often cited by papers focused on Hepatitis C virus research (54 papers), Liver Disease Diagnosis and Treatment (35 papers) and HIV/AIDS drug development and treatment (24 papers). Dolores Merino collaborates with scholars based in Spain, Chile and United States. Dolores Merino's co-authors include Juan A. Pineda, Juan Macı́as, Antonio Rivero, Luís F. López‐Cortés, Francisco Téllez, Ángela Camacho, Antonio Rivero‐Juárez, Nicolás Merchante, Mercedes González‐Serrano and Ignacio de los Santos and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Dolores Merino

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dolores Merino Spain	19	955	916	348	98	88	68	1.2k
Mercedes González‐Serrano Spain	16	1.0k 1.1×	1.0k 1.1×	391 1.1×	105 1.1×	119 1.4×	20	1.3k
Nicolás Merchante Spain	21	1.1k 1.1×	980 1.1×	406 1.2×	89 0.9×	181 2.1×	64	1.4k
Francisco Téllez Spain	18	644 0.7×	710 0.8×	262 0.8×	95 1.0×	59 0.7×	76	1.0k
Patrick Ingiliz Germany	24	1.5k 1.5×	1.4k 1.6×	384 1.1×	71 0.7×	103 1.2×	98	1.8k
Yvonne Higgins United States	15	611 0.6×	607 0.7×	255 0.7×	83 0.8×	126 1.4×	22	907
Elina Teicher France	19	527 0.6×	458 0.5×	459 1.3×	168 1.7×	268 3.0×	41	1.1k
Norbert Bräu United States	24	1.9k 2.0×	1.6k 1.8×	617 1.8×	103 1.1×	147 1.7×	68	2.2k
K. McGowan United States	8	643 0.7×	632 0.7×	486 1.4×	148 1.5×	117 1.3×	10	984
José Ángel García-García Spain	16	827 0.9×	826 0.9×	413 1.2×	191 1.9×	207 2.4×	35	1.3k
Gabriella Verucchi Italy	21	1.5k 1.6×	1.5k 1.6×	286 0.8×	173 1.8×	152 1.7×	86	2.0k

Countries citing papers authored by Dolores Merino

Since Specialization

Citations

This map shows the geographic impact of Dolores Merino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dolores Merino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dolores Merino more than expected).

Fields of papers citing papers by Dolores Merino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dolores Merino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dolores Merino. The network helps show where Dolores Merino may publish in the future.

Co-authorship network of co-authors of Dolores Merino

This figure shows the co-authorship network connecting the top 25 collaborators of Dolores Merino. A scholar is included among the top collaborators of Dolores Merino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dolores Merino. Dolores Merino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamaguchi, Takanori, et al.. (2023). Peak frequency mapping to differentiate near-field from far-field electrograms for ventricular tachycardia ablation: initial results. EP Europace. 25(Supplement_1). 2 indexed citations

González‐Serna, Alejandro, Anaïs Corma‐Gómez, Francisco Téllez, et al.. (2023). Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice. Journal of Antimicrobial Chemotherapy. 78(10). 2591–2596. 4 indexed citations

Corma‐Gómez, Anaïs, Juan Macı́as, Antonio Rivero, et al.. (2021). A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure. Diagnostics. 11(8). 1501–1501. 1 indexed citations

González‐Serna, Alejandro, Anaïs Corma‐Gómez, Francisco Téllez, et al.. (2021). Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. Journal of Antimicrobial Chemotherapy. 76(9). 2375–2379. 3 indexed citations

Corma‐Gómez, Anaïs, Juan Macı́as, Francisco Téllez, et al.. (2021). Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response. AIDS. 35(13). 2119–2127. 3 indexed citations

Real, Luís Miguel, Marta Fernández‐Fuertes, María Eugenia Sáez, et al.. (2019). A genome‐wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study). Liver International. 39(10). 1918–1926. 3 indexed citations

Macı́as, Juan, Luís Morano, Francisco Téllez, et al.. (2019). Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. Journal of Hepatology. 71(1). 45–51. 44 indexed citations

Castro, Rui, Rafael Granados, Juan Macı́as, et al.. (2018). Impact of interferon‐free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real‐life cohort. Journal of Viral Hepatitis. 25(6). 699–706. 12 indexed citations

Real, Luís Miguel, Juan Macı́as, Ana Belén Pérez, et al.. (2018). Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life. Scientific Reports. 8(1). 14905–14905. 3 indexed citations

10.

Macı́as, Juan, Rafael Granados, Francisco Téllez, et al.. (2018). Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection. Journal of Viral Hepatitis. 26(1). 16–24. 10 indexed citations

11.

Macı́as, Juan, Francisco Téllez, Antonio Rivero‐Juárez, et al.. (2018). Early emergence of opportunistic infections after starting direct‐acting antiviral drugs in HIV/HCV‐coinfected patients. Journal of Viral Hepatitis. 26(1). 48–54. 4 indexed citations

12.

Cuypers, Lize, Ana Belén Pérez, Natalia Chueca, et al.. (2018). Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis. PLoS ONE. 13(7). e0201268–e0201268. 11 indexed citations

13.

Rivero‐Juárez, Antonio, Luís F. López‐Cortés, Dolores Merino, et al.. (2016). Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy. European Journal of Clinical Microbiology & Infectious Diseases. 36(3). 487–494. 8 indexed citations

14.

Macı́as, Juan, Ángela Camacho, Miguel Ángel von Wichmann, et al.. (2013). Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients. AIDS. 27(16). 2541–2549. 24 indexed citations

15.

Rivero‐Juárez, Antonio, José Antonio López Mira, Ignacio de los Santos, et al.. (2012). Short Communication: Atazanavir-Based Therapy Is Associated with Higher Hepatitis C Viral Load in HIV Type 1-Infected Subjects with Untreated Hepatitis C. AIDS Research and Human Retroviruses. 29(2). 223–225.

16.

Mira, J, Antonio Rivero, Ignacio de los Santos, et al.. (2012). Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis. Clinical Infectious Diseases. 55(12). 1719–1726. 12 indexed citations

17.

Merchante, Nicolás, Luís F. López‐Cortés, Maria José Ríos-Villegas, et al.. (2011). Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100 mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Patient Care and STDs. 25(7). 395–402. 7 indexed citations

18.

López‐Cortés, Luís F., Pompeyo Viciana, Rosa Ruiz-Valderas, et al.. (2010). Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study. AIDS Research and Therapy. 7(1). 5–5. 4 indexed citations

19.

Mira, José Antonio López, Alicia Gutiérrez‐Valencia, Ignacio de los Santos, et al.. (2009). Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression. Clinical Infectious Diseases. 49(8). e84–e91. 14 indexed citations

20.

Macı́as, Juan, José Antonio López Mira, Luís F. López‐Cortés, et al.. (2006). Antiretroviral Therapy Based on Protease Inhibitors as a Protective Factor against Liver Fibrosis Progression in Patients with Chronic Hepatitis C. Antiviral Therapy. 11(7). 839–846. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact